...
首页> 外文期刊>Experimental and therapeutic medicine >CT-guided I-125 seed implantation for inoperable retroperitoneal sarcoma: A technique for delivery of local tumor brachytherapy
【24h】

CT-guided I-125 seed implantation for inoperable retroperitoneal sarcoma: A technique for delivery of local tumor brachytherapy

机译:CT引导的I-125种子植入治疗无法手术的腹膜后肉瘤:一种用于局部肿瘤近距离放射治疗的技术

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Radical surgery is currently the first treatment of choice for retroperitoneal soft tissue sarcoma (RSTS). However, the prognosis of RSTS remains poor due to ineffective local control and a high incidence of metastasis after surgical resection. Brachytherapy has been shown to safely provide local radiotherapy for numerous types of cancer when used alone or in combination with surgical resection, but has not been well characterized in the management of RSTS. The aim of this study was to evaluate CT-guided I-125 seed implantation for local control and pain relief in the treatment of inoperable RSTS. A total of 23 patients with RSTS were treated with I-125 implantation. Pain was assessed using a visual analog scale. Other endpoints were evaluated via computed tomography scan or phone call/e-mail records. The occurrence of complications was assessed preoperatively (baseline) and during postoperatively follow-up or until patient succumbed. All patients were successfully treated with I-125 implantation. A mean number of 70.87 radioactive seeds were applied in each patient. During the follow-up, two patients were unaccounted for, local recurrence occurred in three patients, five succumbed and complications were observed in sixteen. The patient's VAS score changed from 7.4 preoperatively to 7.6, 2.3, 2.0, 1.2, 1.5, 1.4 and 2.5 at 24 h, 1, 3, 6, 12, 24 and 36 months after the procedure, respectively. Good local control and significant pain relief after I-125 seed implantation was observed in patients with inoperable RSTS. Thus, the present results suggest that this method could be an effective treatment option for patients with inoperable RSTS.
机译:根治性手术是目前腹膜后软组织肉瘤(RSTS)的首选治疗方法。然而,由于无效的局部控制和手术切除后转移的高发生率,RSTS的预后仍然很差。当单独或与手术切除术结合使用时,近距离放射疗法已被证明可以安全地为多种类型的癌症提供局部放疗,但在RSTS的治疗中尚未得到很好的表征。这项研究的目的是评估CT引导的I-125种子植入在不能手术的RSTS治疗中的局部控制和止痛效果。总共23例RSTS患者接受了I-125植入治疗。使用视觉模拟量表评估疼痛。其他端点是通过计算机断层扫描或电话/电子邮件记录进行评估的。术前(基线)和术后随访期间或直至患者屈服之前评估并发症的发生。所有患者均成功接受I-125植入治疗。每位患者平均使用70.87颗放射性种子。在随访期间,有2例患者不明,3例发生局部复发,5例死于并发症,16例观察到并发症。术后24 h,1、3、6、12、24和36个月,患者的VAS评分分别从术前7.4变为7.6、2.3、2.0、1.2、1.5、1.4和2.5。在无法手术的RSTS患者中观察到I-125种子植入后良好的局部控制和明显的疼痛缓解。因此,目前的结果表明该方法对于不能手术的RSTS患者可能是一种有效的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号